文献速递甲状腺疾病

妊娠期甲状腺功能减退症状主要与甲状腺素而非促甲状腺激素浓度相关

Hypothyroid Symptoms Throughout Pregnancy Are Predominantly Associated with Thyroxine and Not with Thyrotropin Concentrations.
PubMed 文献 · Thyroid · 2022-09-20

该前瞻性队列研究纳入1800名健康孕妇,在早中晚孕期用12项甲减症状清单和爱丁堡抑郁量表评估,发现临床甲减和低甲状腺素血症孕妇的甲减症状评分高于甲状腺功能正常对照和亚临床甲减孕妇,而亚临床甲减孕妇中82%的fT4处于正常范围;fT4从孕早期至孕晚期下降与持续高甲减症状相关,校正抑郁后fT4每下降1 pmol/L,持续高甲减症状的可能性增加46%。

要点

  • 临床甲减和低甲状腺素血症孕妇的甲减症状评分高于甲状腺功能正常对照和亚临床甲减孕妇。
  • 亚临床甲减孕妇中82%的fT4水平处于甲状腺功能正常范围。
  • 校正抑郁后,fT4每下降1 pmol/L,持续高甲减症状的可能性增加46%。

核心结论

  • 定义恰当的甲状腺功能正常对照组可区分有甲减症状的孕妇。
  • fT4向足月妊娠下降与持续高甲减症状水平相关。
  • 临床医生应认识到亚临床甲减孕妇中进行fT4分层的重要性。

研究设计与样本

  • 纵向前瞻性队列研究,纳入1800名健康孕妇。
  • 每个孕期用12项甲减症状清单评估甲减症状,用爱丁堡抑郁量表评估抑郁症状。
  • 甲状腺功能障碍用甲状腺过氧化物酶抗体阴性女性的fT4/TSH第2.5-97.5百分位定义。
  • 甲状腺功能正常对照为fT4在第10-90百分位且TSH正常者。
  • 采用生长混合模型评估甲减和抑郁症状的纵向轨迹,用多因素logistic回归分析甲减症状轨迹(校正抑郁)与fT4/TSH变化的关联。

主要发现

  • 临床甲减(fT4<第2.5百分位,TSH>第97.5百分位)和低甲状腺素血症(fT4<第2.5百分位,TSH在第2.5-97.5百分位)孕妇的甲减症状水平高于甲状腺功能正常对照和亚临床甲减(fT4在第2.5-97.5百分位,TSH>第97.5百分位)孕妇,因为82%的亚临床甲减孕妇fT4处于甲状腺功能正常范围。
  • 甲减和抑郁症状各定义出两组:持续低症状组和持续高症状组。
  • 98%的孕妇从孕早期至孕晚期fT4下降,校正抑郁后,fT4每下降1 pmol/L(而非TSH升高),持续高甲减症状的可能性增加46%。

临床怎么用

  • 临床医生应认识到亚临床甲减孕妇中进行fT4分层的重要性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: It is unclear whether levels of hypothyroid symptoms in pregnant women with (sub)clinical thyroid dysfunction differ from euthyroid controls and whether free thyroxine (fT4)/thyrotropin (TSH) changes throughout pregnancy affect hypothyroid symptom levels. The objective was twofold: (1) To compare hypothyroid symptom levels between thyroid dysfunction subgroups and a carefully defined reference group; (2) to assess the association between fT4/TSH changes throughout pregnancy and hypothyroid symptom levels adjusted for depressive symptoms. Methods: The current study was a longitudinal prospective cohort study in 1800 healthy pregnant women. At each trimester of pregnancy, hypothyroid symptoms were assessed with a 12-item symptom hypothyroidism checklist and depressive symptoms with the Edinburgh Depression Scale. Thyroid dysfunction was defined using the 2.5-97.5th fT4/TSH percentile of thyroid peroxidase antibodies-negative women. Euthyroid controls consisted of women with appropriate fT4 levels within the 10-90th percentile and with a normal TSH level. Hypothyroid symptom mean scores were compared between controls and several thyroid dysfunction subgroups. Growth mixture modeling was performed to evaluate possible longitudinal trajectories of hypothyroid and depressive symptoms. The association between hypothyroid symptom trajectories (adjusted for depression) and fT4/TSH changes was assessed with multivariate logistic regression analysis. Results: Women with overt hypothyroidism (fT4 < 2.5th, TSH >97.5th) and hypothyroxinemia (fT4 < 2.5th, TSH: 2.5-97.5th) showed higher hypothyroid symptom levels compared with the euthyroid controls and women with subclinical hypothyroidism (SCH, fT4: 2.5-97.5th, TSH >97.5th), because 82% of these SCH women had fT4 levels in the euthyroid range. Two groups of hypothyroid and depressive symptoms were defined: a persistently low and persistently high symptom group. fT4 decreased in 98% of the women from the first to third trimester and per unit pmol/L fT4 decrease (not TSH increase), the likelihood to present persistently high hypothyroid symptoms increased with 46%, adjusted for depression. Conclusions: A properly defined euthyroid control group distinguishes women with hypothyroid symptoms. An fT4 decrease toward end term is associated with persistently high hypothyroid symptom levels. Clinicians should be aware of the importance of fT4 stratification in SCH women.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Pop VJ, Hulsbosch LP, Boekhorst MGBM, et al. Hypothyroid Symptoms Throughout Pregnancy Are Predominantly Associated with Thyroxine and Not with Thyrotropin Concentrations. Thyroid. 2022. PMID: 35999708. doi:10.1089/thy.2022.0244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。